Streamex Corp. (STEX) Stock

Streamex Corp. (STEX) is a Healthcare stock trading at $0.91 (as of 2026-06-18), with a market capitalization of $157.45M and a trailing P/E of -0.2. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

BioSig Technologies, Inc. recently rebranded as Streamex Corp., effective September 12, 2025, following its merger with Streamex Exchange Corporation. The company shifted focus from healthcare technology to real-world asset tokenization, especially integrating the gold and commodities market into blockchain technology. Streamex provides institutional-grade infrastructure for tokenizing assets powered by a gold-denominated treasury.

Valuation — source: SEC EDGAR (first-party)
Price$0.91
Market Cap$157.45M
P/E Ratio-0.2
EV / EBITDA-1.5
Price / Book0.99
Price / Sales3936.37
DCF Value (model)$-1.61
DCF Upside vs Price-277.0%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$40000.00
Net Margin-25825.0%
Return on Equity-318.2%
Current Ratio13.90
Revenue Growth (YoY)122.2%
EPS Growth (YoY)-81.0%
Valuation vs Sector & Industry
Stock P/E-0.2
Sector P/E (Healthcare)21.0
Industry P/E (Medical Equipment)31.7
vs Sector-100.7%
vs Industry-100.5%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderLegacy Wealth Managment, LLC/ID ($7.94M)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryMedical Equipment
CEOKarl Henry McPhie
Employees5
CountryUS
IPO Date2025-09-12

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

  • InfuSystem Holdings, Inc. (INFU)
  • OraSure Technologies, Inc. (OSUR)
  • Apyx Medical Corporation (APYX)
  • Lucid Diagnostics Inc. (LUCD)
  • Pro-Dex, Inc. (PDEX)
  • Microbot Medical Inc. (MBOT)
  • Anika Therapeutics, Inc. (ANIK)
  • Rapid Micro Biosystems, Inc. (RPID)
STEX earnings history · STEX institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.